<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Trieste_parts_5"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:Trieste/parts/5">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Trieste/parts/5&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Trieste/parts/5&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Trieste/parts/5&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Trieste/parts/5" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Trieste/parts/5</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2012.igem.org</H3><DIV id="head"><TITLE>Team Trieste iGEM 2012</TITLE></DIV><DIV id="body"><DIV id="container"><DIV id="header"><DIV id="payoff">The Jolly JoCare<DIV>a safe probiotic platform for protein expression</DIV></DIV><UL id="navigation"><LI><A href="https://2012.igem.org/Team:Trieste">HOME</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/team">TEAM</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/team">Team</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/City&amp;Lab">City&amp;Lab</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/Team Gal">Team Gallery</A></LI></UL><LI><A href="https://2012.igem.org/Team:Trieste/project">PROJECT</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project">Abstract</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/overview">Project Overview</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/applications">Applications</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/modeling">Modeling</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/project/mainres">Main Results</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/data">DATA</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/parts">PARTS</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/notebook">DIARY</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/notebook">Notebook</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/protocols">Protocols</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/safety">SAFETY</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/safety">Safety</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/survey">Safety Survey</A></LI><LI><A href="http://www.icgeb.org/~bsafesrv/" target="_blank">ICGEB Safety Unit</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/outreach">OUTREACH</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/outreach">Human Practice</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/outreach/press">Press</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/extra">EXTRA</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/extra">Attributions</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/extra/ach">Achievements</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/extra/aks">Acknowledgement</A></LI></DIV><DIV id="content"><H1 id="h1_lf" class="main_tit"><DIV>BBa_K875005</DIV></H1><H1 id="h1_rt" class="main_tit"><DIV>More</DIV></H1><DIV id="box_main"><DIV class="box_contenuti"><H2>Description </H2>
This construct is designed for the expression of an already described engineered antinorovirus (NoV) monoclonal antibody (mAb 54.6) in fusion with LPP-OmpA.
The antibody is expressed in a small immuno protein (SIP) format containing light (VL) and heavy (VH) variable domains separeted by a flexible peptide linker and constant domain (CH3) of heavy chain of human immunoglobulin A (IgA). It has already been reported that the scFv 54.6 (which compones SIP) binds a native recombinant NoV particles (VLPs) and inhibits VLP interaction with cells. Alpha isotype CH3 domain homodimerizes confering bivalent binding properties to the antibody.
LPP-OmpA functions as a leader sequence and an anchor to display the scFv ot the bacterial surface.

The construct consistes of T5 Lac Operator (Bba_K875002), ribosomal binding site, LPP-OmpA, scFv 54.6 antinorovirus, Hystidine tag (6HIS), Terminator (B0015).

The expression of chimeric protein LPP-OmpA-SIP 54.6-6HIS is regulated by T5 Lac Operator (Bba_K875002). When the promoter T5 Lac O is induced with IPTG (1mM), the fusion protein LPP-OmpA-SIP 54.6-6HIS is expected to be expressed extracellularly on the bacterial surface. LPP-OmpA introduces itself into the outer membrane displaying extracellularly the antibody attached on its C-terminus. 

Molecular Weight: 60 kDa. 

<H2>Assembly</H2>
The sequence LPP-OmpA-SIP was obtained by synthesis.
<H2>Results</H2>
The cloning success has been verified by Colony PCR. (Fig. 1)
The construct has been completely sequenced. 
<P class="didascalia"><STRONG>FIG.1 Electrophoresis in gel 1% agarose whit ethidium bromide of T5LacO-LPP-OmpA-SIP-6His-TT (blue box).</STRONG> Fragment LPP-OmpA-SIP-6His-TT, previously double digested with XbaI/PstI, was then cloned downstream the T5LacOperator in plasmid pSB1C3 double digested with SpeI/PstI. 
</P> 
The construct was tested in <I>E.coli</I> W3110 strain which was previously trasformed with p-REP 4 encoding for the Lac Repressor. The recombinant bacterial culture was induced at O.D.= 0.4 (2x108 bacterial cells/ml) with IPTG (1mM) at 37°C in shaker. 2ml of bacterial culture were centrifuged and the pellet was resuspended in 200μl of lysis buffer. The samples were then sonicated and boiled for 5 min. 10μl of lysates of induced, non-induced and non trasformed bacterial cultures were resolved on SDS-PAGE. The expression of  fusion protein LPP-OmpA-scFv 54.6-His was tested by Western blotting with anti-6HIS antibodies (Fig. 2).
<P class="didascalia"><STRONG>FIG. 2. Expression of SIP 54.6 cloned in fusion with the LPP-OmpA leader sequence.</STRONG> Western blots of lysates of <I>E.coli</I> W3110 bacterial strain expressing the recombinant protein SIP 54.6 (60KDa), induced or non-induced with IPTG. The blot was reacted with the Affinity purified antibody goat anti-Human IgA(α). 
 </P>

Western blot with anti-6HIS antibodies showed the band corresponding to SIP 54.6 at the expected position in the IPTG-induced sample. In the non-induced sample, a weaker signal is also detected suggesting that the promoter is leaky; aspecific signals are also visible. Some of them are due to partially degraded protein.


Reference:

1. “Transport and anchoring of 8-lactamase to the external surface of
     Escherichia coli” J. A. Francisco, C. F. Earhart and G. Georgiou.
     Proc. Natl. Acad. Sci. USA Vol. 89, pp. 2713-2717, April 1992 Biochemistry.

2. “Recombinant norovirus-specific scFv inhibit virus-like particle binding to      
    cellular ligands” K. Ettayebi and M. E. Hardy. 
    Published: 31 January 2008 in Virology Journal 2008, 5:21
<H2>Looking forward</H2>
In the next step we will clone the LPP-OmpA-SIP under the constitutive promoter BBa_J23100 and transform it in E.coli Nissle 1917.
<H3><A href="http://partsregistry.org/Part:BBa_K875005" target="_blank">Link to the Registry</A></H3></DIV></DIV><DIV id="box_right"><UL id="sub_menu"><LI><STRONG><A href="https://2012.igem.org/Team:Trieste/parts">Overwiev</A></STRONG></LI><LI><A href="https://2012.igem.org/Team:Trieste/parts/1">BBa_K875001 - Cumate Op</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/parts/2">BBa_K875002 - Lac OP</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/parts/3">BBa_K875003 - CymR</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/parts/4">BBa_K875004 - OmpA scFv</A></LI><LI class="select"><A href="https://2012.igem.org/Team:Trieste/parts/5">BBa_K875005 - OmpA SIP</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/parts/6">BBa_K875006 - PelB scFv</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/parts/7">BBa_K875007 - PelB SIP </A></LI><LI><A href="https://2012.igem.org/Team:Trieste/parts/8">BBa_K875008 - Tse2 Toxin</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/parts/9">BBa_K875009 - LL 37</A></LI><LI><A href="https://2012.igem.org/Team:Trieste/parts/10">BBa_K875020 - Glucosidase</A></LI></UL><DIV class="box_contacts"><H2>Contact us</H2><P>For other information, write to:</P><A href="mailto:igem2012@gmail.com" class="btn">igem2012@gmail.com</A><DIV class="social">
                    Follow us also:
			</DIV></DIV></DIV></DIV><DIV id="footer"><DIV id="box_footer">iGEM 2012 - For info: <A href="mailto:igem2012@gmail.com">igem2012@gmail.com</A></DIV></DIV></DIV></DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2012.igem.org/Team:Trieste/parts/5">http://2012.igem.org/Team:Trieste/parts/5</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Trieste/parts/5" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Trieste/parts/5" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Trieste/parts/5&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Trieste/parts/5&amp;oldid=230793" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2012.igem.org:Privacy_policy" title="2012.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2012.igem.org:General_disclaimer" title="2012.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>